1% Lidocaine Hci Injection, Solution
Product Images NDC 51662-1465

Product Visual Gallery

This gallery contains 18 technical images submitted to the FDA as part of the official labeling for 1% Lidocaine Hci (NDC 51662-1465). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662-1465-1 Serialized Labeling (51662 1465 1 Serialized Labeling)

2% Lidocaine HCl injection solution in a 20 mL multiple-dose vial with a purple cap. The label shows strength as 1% (10 mg/mL) with a total of 200 mg/20 mL. Distributed by HF Acquisition Co LLC, DBA HealthFirst. Includes a barcode and lot number 01-238-DK.*

FDA Label Image

Principal Display Panel (51662-1465-1 20 mL VIAL LABEL OPT 1)

Label for Lidocaine HCl Injection, USP 1% (10 mg/mL) in a 20 mL multiple-dose vial, with a total of 200 mg per 20 mL. The label states use for infiltration and nerve block, excludes epidural and caudal use, and notes the preservative content. It is labeled by Hospira, Inc., Lake Forest, IL, with NDC 0409-4276-16.*

FDA Label Image

Principal Display Panel (51662-1465-1 20 mL VIAL LABEL OPT 2)

2% Lidocaine HCl Injection, USP label for a 20 mL multiple-dose vial, showing 200 mg/20 mL (10 mg/mL) strength. The label displays the product name, dosage form, concentration, route of administration for infiltration and nerve block, storage instructions, preservative warning, and placeholder text for lot and expiration date information. The labeler is HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Principal Display Panel (51662-1465-1 20 mL VIAL LABEL OPT 3)

Label for Lidocaine HCl Injection, USP 1% (10 mg/mL) in a 20 mL multiple-dose vial. The label states the total drug amount as 200 mg per 20 mL and includes usage for infiltration and nerve block. It warns against epidural and caudal use and notes the product contains a preservative. The label shows lot and expiration placeholders and manufacturer as Hospira, Inc.*

FDA Label Image

Principal Display Panel (51662-1465-1 20 mL VIAL LABEL OPT 4)

Label for Lidocaine HCl Injection, USP 1% (10 mg/mL) solution in a 20 mL multiple-dose vial. The label states the strength as 200 mg/20 mL and indicates its use for infiltration and nerve block. It includes a warning that it is not for epidural and caudal use and contains a preservative. The label also lists the manufacturer as Hospira, Inc.*

FDA Label Image

Principal Display Panel (SERIALIZED LABELING 51662-1467-1 20 mL VIAL)

Bottle label for 2% Lidocaine HCl Injection, USP, 20 mL multiple-dose vial. The label indicates a strength of 2% (20 mg/mL) with total of 400 mg per 20 mL. Distributed by HF Acquisition Co., LLC. The label shows a blue cap and includes a barcode and lot number information.*

FDA Label Image

Principal Display Panel (51662-1467-1 20 mL VIAL LABEL OPT 1)

Label for 2% Lidocaine HCl Injection, USP, 400 mg/20 mL (20 mg/mL), multiple-dose vial. The label indicates the product is for infiltration and nerve block, not for epidural and caudal use, and contains a preservative. The labeler is Hospira, Inc., Lake Forest, IL, USA.*

FDA Label Image

Principal Display Panel (51662-1467-1 20 mL VIAL LABEL OPT 2)

Label for 2% Lidocaine HCl Injection, USP 400 mg/20 mL (20 mg/mL) multiple-dose vial. The label specifies use for infiltration and nerve block, excluding epidural and caudal use, and notes a preservative is included. It lists the active ingredient content per mL and includes storage instructions. Distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (51662-1467-1 20 mL VIAL LABEL OPT 3)

Label for 2% Lidocaine HCl Injection, USP, 400 mg/20 mL (20 mg/mL), multiple-dose vial. The 20 mL solution is for infiltration and nerve block, labeled as Rx only and not for epidural or caudal use. Contains preservatives and lists the manufacturer as Hospira, Inc., Lake Forest, IL.*

FDA Label Image

Principal Display Panel (51662-1467-1 20 mL VIAL LABEL OPT 4)

2% Lidocaine HCl Injection, USP 400 mg/20 mL (20 mg/mL) is a multiple-dose vial with a 20 mL capacity. The label specifies it is for infiltration and perineural use and is distributed by HF Acquisition Co LLC, DBA HealthFirst. The label includes lot and expiration date fields and important storage and usage instructions.*

FDA Label Image

Description (Description)

A table displaying concentrations of lidocaine HCl and sodium chloride in solutions of 0.5%, 1%, 1.5%, and 2% lidocaine HCl. It shows mg/mL values of lidocaine HCl ranging from 5 to 20 and sodium chloride ranging from 8 to 6 across these concentrations.*

FDA Label Image

D & A 1 (Dosage And Administration 1)

A table presenting the packaging options for 2% Lidocaine HCl injection solution, showing vial or ampul volumes for different concentrations: 1% concentration in 30 mL single-dose teartop vials, 1.5% in 20 mL single-dose ampuls, and 2% in 10 mL single-dose ampuls.*

FDA Label Image

D A A 2 (Dosage And Administration 2)

A dosage table for Lidocaine Hydrochloride Injection, USP without Epinephrine, detailing procedures such as infiltration, peripheral nerve blocks, sympathetic nerve blocks, and central neural blocks. It lists concentrations (%), volumes (mL), and total doses (mg) for various medical uses like brachial, dental, epidural, and surgical anesthesia.*

FDA Label Image

How Supplied 1 (How Supplied 1)

A data table listing multiple units of sale and concentrations for 2% Lidocaine HCl injection solution. It includes NDC codes, package descriptions such as trays or cartons of glass vials or ampuls, and corresponding concentrations ranging from 0.5% to 2%, with specific mg/mL and total mg/mL values per package size.*

FDA Label Image

How Supplied 2 (How Supplied 2)

A table listing various units of sale and concentrations for lidocaine injection solutions, including bundles of clamcells with ampuls and trays of plastic fliptop vials. The table details NDC codes, package sizes, concentration percentages, and corresponding mg/mL values for 0.5%, 1%, and 2% lidocaine formulations.*

FDA Label Image

Logo (Logo)

FDA Label Image

Precautions (Precautions)

A data table listing various drug classes in one column and examples of drugs in those classes in the other. Classes include Nitrates/Nitrites, Local anesthetics, Antineoplastic agents, Antibiotics, Antimalarials, Anticonvulsants, and Other drugs, with corresponding drug examples such as lidocaine under local anesthetics, and phenobarbital under anticonvulsants.*

FDA Label Image

Structure (Structure)

Chemical structure diagram of 2% Lidocaine HCl, showing the aromatic ring with methyl groups and the molecular formula indicating the hydrochloride and water components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.